Detection of altered methylation of MB-COMT promotor and DRD2 gene in cannabinoid or synthetic cannabinoid use disorder regarding gene variants and clinical parameters-Reference-Cited by-同舟云学术

Detection of altered methylation of MB-COMT promotor and DRD2 gene in cannabinoid or synthetic cannabinoid use disorder regarding gene variants and clinical parameters

Published:2021-03-29 Issue:4 Volume:39 Page:526-536
ISSN:1055-0887
Container-title:Journal of Addictive Diseases
language:en
Short-container-title:Journal of Addictive Diseases

Author:

Oyaci Yasemin¹^ORCID,Aytac Hasan Mervan²^ORCID,Pasin Ozge³^ORCID,Cetinay Aydin Pinar⁴^ORCID,Pehlivan Sacide¹^ORCID

Affiliation:

1. Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

2. Department of Psychiatry, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey

3. Department of Biostatistics, Faculty of Medicine, Istanbul University, Istanbul, Turkey

4. Department of Psychiatry, University of Health Sciences, Psychiatry Clinic, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey

Funder

Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology,General Medicine,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/10550887.2021.1906618

Reference58 articles.

1. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies

2. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

3. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies